4547:TYO
Kissei Pharmaceutical Co Ltd
3 690,00 JP¥
arrow_downward
-0,27%(-10,00) 1D
5-окт., 14:56:25 GMT+9 · JPY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4547...
Open
3 705 JP¥
High
3 720 JP¥
Low
3 670 JP¥
Mkt. cap
171,74 млд
Avg. vol.
68,01 миң
Volume
48,60 миң
Dividend
3,25%
Quarterly dividend
30 JP¥
Ex-dividend date
2026-ж., 29-сен.
P/E ratio
10,94
52-wk high
5 040 JP¥
52-wk low
3 500 JP¥
EPS
337 JP¥
Shares outstanding
46,72 млн
No. of employees
2 миң
Open
3 705 JP¥
High
3 720 JP¥
Low
3 670 JP¥
Mkt. cap
171,74 млд
Avg. vol.
68,01 миң
Volume
48,60 миң
Dividend
3,25%
Quarterly dividend
30 JP¥
Ex-dividend date
2026-ж., 29-сен.
P/E ratio
10,94
52-wk high
5 040 JP¥
52-wk low
3 500 JP¥
EPS
337 JP¥
Shares outstanding
46,72 млн
No. of employees
2 миң
News stories
From web sources and news partners
Briefs Finance
·
18 мүнөт мурун
OKX and ICE Launch Tokenized NYSE Stocks
Benzinga
·
8 мүнөт мурун
Stock Market: Will S&P 500 Open Up or Down Today?
www.marketscreener.com
·
20 мүнөт мурун
Panmure Liberum sets 2027 year-end S&P 500 target at 5,000
Profile
Kissei Pharmaceutical is a pharmaceutical company based in Matsumoto, Nagano, Japan. Products discovered or developed by Kissei include:
Difelikefalin
Fostamatinib
Linzagolix
Mitiglinide
Remogliflozin etabonate
Silodosin
Tranilast
In March 2020, Kissei and CG Oncology, Inc. announced an exclusive license, development, and commercialization agreement for CG's oncolytic immunotherapy drug CG0070. The agreement covered Japan, South Korea, Taiwan, and other Asian countries, but not China. Wikipedia
About Kissei Pharmaceutical Co Ltd
CEOMutsuo Kanzawa
Employees1,79 миң
Founded1946-ж., 9-авг.
HeadquartersMatsumoto, Nagano, Япония
SectorPharmaceutical industry
Websitekissei.co.jp